Key Funding Incentives
1 | Federal R&D Tax Credit and Expensing (Section 174)
The federal Research & Development (R&D) Tax Credit is a cornerstone incentive designed to encourage businesses to invest in innovative activities.
Mechanism (Tax Credit): The R&D tax credit provides a dollar-for-dollar reduction in a company’s federal income tax liability. The credit calculation can be complex, typically equating to 7% to 10% of annual R&D spending. Companies, particularly qualified small businesses (QSBS), can elect to use a portion of their R&D credit (up to $250,000 annually) to offset payroll taxes, providing a crucial benefit for early-stage companies with little to no income tax liability.
Mechanism (R&D Expensing – Section 174): A key legislative change (The “One Big Beautiful Bill Act” or OBBBA, signed July 4, 2025) restored the immediate deduction (full expensing) of domestic R&D costs, reversing the 2022 requirement to amortise them over five years. This change is effective for tax years beginning after December 31, 2024.
-
- Impact of Expensing: Immediate expensing significantly reduces taxable income in the year R&D occurs, substantially improving cash flow.
-
- Foreign R&D: R&D performed outside the U.S. must still be amortised over 15 years.
-
- Retroactive Relief: Eligible small businesses (average annual gross receipts of $31 million or less) may elect to apply the full expensing rules retroactively to tax years 2022–2024.
Eligibility: Activities must meet a “four-part test” involving technological uncertainty and a process of experimentation. Eligible expenditures include wages for R&D employees, materials/supplies used in research, contractor costs, and computer hosting costs.
Impact: The combination of the permanent tax credit and the restored immediate deduction makes the U.S. a highly attractive location for corporate R&D investment.
2 | Sector-Specific Strategic Funding (CHIPS and Science Act)
Major federal legislation has established unprecedented funding levels for R&D and manufacturing in critical technology sectors.
CHIPS Act of 2022: This Act provides vast funding and incentives to bolster domestic semiconductor manufacturing and research.
-
- Manufacturing Incentives: Includes over $52 billion in direct funding for semiconductor manufacturing, plus an Advanced
-
- Manufacturing Investment Tax Credit (ITC) equal to 25% of qualified investment costs for advanced semiconductor manufacturing facilities.
-
- R&D Ecosystem: Provides funding for the National Semiconductor Technology Center (NSTC) and other programmes aimed at R&D, advanced packaging, and workforce development.
Science Act of 2022: Authorises significant budget increases for agencies like the NSF, NIST, and DOE to support research in critical and emerging technologies (CET) like AI, quantum, and biotechnology.
-
- Tech Hubs Program: Authorises funding (up to $10 billion) to designate and fund Regional Technology and Innovation Hubs (Tech Hubs) across the country, aiming to accelerate technology commercialisation in specific regions and CET areas.
Impact: This massive injection of capital is designed to secure U.S. supply chains, enhance national security, and ensure U.S. global leadership in key industries by funding the entire innovation chain from basic research to full-scale manufacturing.
3 | Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) Programs
Often referred to as “America’s Seed Fund,” the SBIR and STTR programs are highly competitive federal grant initiatives for small businesses engaged in R&D with commercial potential.
Mechanism (Non-Dilutive Grants): These non-dilutive grants provide capital without requiring equity in return.
-
- Phase I: Focuses on proving scientific or technical merit and feasibility (e.g., maximum award sizes are typically $250,000 to $305,000, depending on the agency).
-
- Phase II: Expands on Phase I results, focusing on the principal R&D effort and evaluating commercialisation potential (e.g., maximum award sizes are typically $1.25 million to over $2 million, depending on the agency, such as NIH’s maximum of $2,095,748).
Participating Agencies: Eleven federal agencies participate, including the NSF, DoD, DoE, and HHS.
Impact: SBIR/STTR are vital sources of early-stage funding for technology-based startups, particularly those developing deep technologies based on fundamental science or engineering.
4 | National Science Foundation (NSF) Grants
The NSF is an independent federal agency that supports fundamental research and education in all non-medical fields of science and engineering.
Focus: NSF’s funding prioritises high-risk, high-reward research, with investments driving advancements in areas like artificial intelligence (AI), quantum technologies, and biotechnology.
Directorate for Technology, Innovation and Partnerships (TIP): Created under the CHIPS and Science Act, the TIP directorate focuses specifically on speeding the translation of research results into practical applications, products, and services, often through new funding models like STRIDE Ventures (in partnership with private groups) and the Regional Innovation Engines program.
Impact: NSF funding is crucial for driving scientific and engineering discoveries that form the bedrock of future innovations and accelerating the development of cutting-edge technologies.
5 | State, Local, and Venture Capital Incentives
In addition to massive federal programmes, the private sector and sub-national governments provide complementary funding.
State & Local Incentives: Most U.S. states and many local governments offer their own R&D tax credits (ranging from 2% to 5%) and targeted grants/loan programmes tailored to regional economic goals (e.g., advanced manufacturing, clean tech).
Venture Capital (VC) Landscape: The U.S. boasts the world’s most mature and active VC ecosystem, providing equity financing to high-growth potential companies. This market is instrumental in scaling innovative companies from concept to global leaders, with current trends focusing heavily on AI/ML, sustainable technologies, and biotechnology.
Impact: The robust U.S. VC market, coupled with targeted state support, drives a significant portion of the nation’s innovation and accounts for the final-stage capital required for mass commercialisation.
Conclusion
The United States’ innovation funding incentives form a comprehensive and highly effective framework designed to foster a dynamic ecosystem for R&D and entrepreneurship. The reinstatement of the immediate R&D expense deduction (Sec 174) in 2025 and the massive, targeted funding from the CHIPS and Science Act reinforce the government’s commitment to reducing financial risk and driving leadership in critical technologies. This robust public sector foundation, coupled with the world’s leading venture capital market, enables the U.S. to maintain its unparalleled position as a global innovation powerhouse.
We’re here to help. Contact us to discuss how ABGi can support your global innovation strategy.
